Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- UK DOH's Expert Group Issues Recommendations on First-in-man Trials of High-risk Agents
January 15, 2007
- R&D NEWS IN BRIEF
January 15, 2007
- 10 Questions for the New Year
January 15, 2007
- Asymptomatic Hepatitis B 57% : Bristol-Myers
January 15, 2007
- Seminar
January 15, 2007
- Korosho to Initiate "Purity Testing" Project for Generics
January 15, 2007
- Blopress Remains Top Selling Drug for 3rd Year in a Row
January 15, 2007
- GENERIC NEWS IN BRIEF
January 15, 2007
- No NHI Price Revision in FY2007: Chuikyo
January 8, 2007
- Gov't Approves 2.5% Budget Increase for Korosho
January 8, 2007
- Council to Begin Drafting Innovation 25 Strategy
January 8, 2007
- REGULATORY NEWS IN BRIEF
January 8, 2007
- STATISTICS
January 8, 2007
- 72% of Smokers Unaware of Insurance Coverage for Smoking Cessation: Novartis
January 8, 2007
- Mr Uchida of ABMJ Expresses High Expectations of Vaccine Study Group
January 8, 2007
- Metabolic Syndrome, Not Alcohol Consumption, Contributes to ALT Elevation
January 8, 2007
- R&D NEWS IN BRIEF
January 8, 2007
- Japan Ranks 5th Among OECD Countries in Health: JPC-SED
January 8, 2007
- JACDS to Review Relationship with JPA
January 8, 2007
- Drug Industry in Japan Has Wind at Its Back
January 8, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…